Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial (Q42147892)

17 October 2017

Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial (English)

1 reference

17 October 2017

David S Yee

1

1 reference

17 October 2017

William T Lowrance

2

1 reference

17 October 2017

James A Eastham

3

1 reference

17 October 2017

Alexandra C Maschino

4

1 reference

17 October 2017

Angel M Cronin

5

1 reference

17 October 2017

Farhang Rabbani

6

1 reference

17 October 2017

8 July 2009

1 reference

17 October 2017

1 reference

17 October 2017

105

1 reference

17 October 2017

2

1 reference

17 October 2017

185-190

1 reference

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: the Canadian experience

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807908

Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer

17 August 2018

1 reference

12 December 2020

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

12 December 2020

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group

1 reference

12 December 2020

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

12 December 2020

Neoadjuvant Hormone Therapy Before Radical Prostatectomy: Update on the Memorial Sloan-Kettering Cancer Center Trials

1 reference

12 December 2020

4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer

1 reference

12 December 2020

New horizons in the surgical management of carcinoma of the prostate gland

1 reference

12 December 2020

The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment

1 reference

12 December 2020

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer

1 reference

12 December 2020

An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series

1 reference

12 December 2020

Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial

1 reference

12 December 2020

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Tr

1 reference

12 December 2020

Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up

1 reference

12 December 2020

Hormone control therapy as a preparation for radical perineal prostatectomy in advanced carcinoma of the prostate

1 reference

12 December 2020

Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer

1 reference

12 December 2020

Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience

1 reference

12 December 2020

Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group

1 reference

12 December 2020

Morphologic changes induced by neoadjuvant androgen ablation may result in underdetection of positive surgical margins and capsular involvement by prostatic adenocarcinoma

1 reference

12 December 2020

Neoadjuvant hormonal therapy: the Canadian experience

1 reference

12 December 2020

10.1111/J.1464-410X.2009.08698.X

Identifiers

DOI

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

19594741

1 reference